Skip to main content
. Author manuscript; available in PMC: 2012 May 30.
Published in final edited form as: J Control Release. 2011 Feb 2;152(1):196–205. doi: 10.1016/j.jconrel.2011.01.029

Figure 4.

Figure 4

Morphology of PMMA/gelatin/antibiotic constructs characterized by A) SEM (scale bars represent 200 µm) and B) microCT (scale bars represent 2 mm, the porosity is indicated at upper left): a porous structure was created by the incorporation of gelatin microparticles; the bulk porosity is controlled by both the percent of gelatin incorporated and the weight ratio of drug solution versus gelatin for swelling.